Patent Assignment
Reel/Frame 028722/0332
Change of Name
Recorded: 2012-08-03
Pages: 9
Assignor
HANMI HOLDINGS CO., LTD.
Executed: 2012-03-27
Assignee
HANMI SCIENCE CO., LTD.
550, DONGTANGIHEUNG-RO, DONGTAN-MYEON, HWASEONG-SI, GYEONGGI-DO, KOREA, REPUBLIC OF
Covered Properties
(39)
P-Glycoprotein Inhibitor, Method for Preparing the Same and Pharmaceutical Composition Comprising the Same
Expression Vector for Secreting Antibody Fragment Using E. Coli Signal Sequence and Method for Mass-Producing Antibody Fragment
Sustained release formulation for oral administration of hmg-coa reductase inhibitor and method for the preparation thereof
Rule Set Verification
Crystalline Monohydrate Clopidogrel Naphthalenedisulfonate and Process of Preparation.
Crystalline S-Omeprazole Strontium Hydrate, Method for Preparing Same, and Pharmaceutical Composition Containing Same
Method for the Preparation of D-Erythro-2,2-Difluoro-2-Deoxy-1-Oxoribose Derivative
1-Alpha-Halo-2,2-Difluoro-2-Deoxy-D-Ribofuranose Derivatives and Process for the Preparation Thereof
Method for the Preparation of 2'-Deoxy-2',2'-Difluorocytidine
Quinazoline Derivatives for Inhibiting Cancer Cell Growth and Method for the Preparation Thereof
Syrup Composition Comprising Dexibupropen as an Active Ingredient and Method for the Preparation Thereof
Application:
11/813,315 →
Publication:
US 2008/0014223
Method of Preparing Clopidogrel and Intermediates Used Therein
Modified Human Granulocyte-Colony Stimulating Factor and Process for Producing Same
Method of Preparing Esomeprazole and Salts Thereof
Solid Dispersion Comprising An Active Ingredient Having A Low Melting Point And Tablet For Oral Administration Comprising Same
Application:
12/097,299 →
Publication:
US 2008/0292702
Pharmaceutical Composition Comprising Amlodipine and Losartan
Application:
12/303,034 →
Publication:
US 2010/0233261
Crystalline S-Omeprazole Strontium Hydrate, Method for Preparing Same, and Pharmaceutical Composition Containing Same
Complex Formulation for Preventing or Treating Osteoporosis Which Comprises Solid Dispersion of Vitamin D or Its Derivative and Bisphosphonate
Application:
12/513,708 →
Publication:
US 2010/0048511
Method of Preparing Docetaxel and Intermediates Used Therein
Application:
12/517,623 →
Publication:
US 2010/0099896
Method of Preparing Taxane Derivatives and Intermediates Used Therein
Application:
12/517,980 →
Publication:
US 2010/0317868
Method of Preparing Montelukast and Intermediates Used Therein
Novel Crystalline Bepotastine Metal Salt Hydrate, Method for Preparing Same, and Pharmaceutical Composition Comprising Same
Application:
12/531,003 →
Publication:
US 2010/0137367
Stable Anhydrous Crystalline Docetaxel and Method for the Preparation Thereof
Application:
12/532,887 →
Publication:
US 2010/0099897
Physiologically Active Polypeptide Conjugate Having Prolonged in Vivo Half-Life
Novel Amide Derivative for Inhibiting the Growth of Cancer Cells
Process for Preparing Bepotastine and Intermediates Used Therein
Application:
12/663,983 →
Publication:
US 2010/0168433
Process for Preparing Voriconazole
Method for Preparation of Montelukast Acid in Ionic Liquid Medium
Method of Preparing (6R)-3-Hexyl-4-Hydroxy-6-Undecyl-5, 6-Dihydropyran-2-One, and Intermediate Used in the Method
Methods for Preparing Capecitabine and Beta-Anomer-Rich Trialkyl Carbonate Compound Used Therein
Crystalline S-Omeprazole Strontium Hydrate, Method for Preparing Same, and Pharmaceutical Composition Containing Same
Method for Preparing (3S,4S)-4-((R)-2-(Benzyloxy)Tridecyl)-3-Hexyl-2-Oxetanone and Novel Intermediate Used Therefor
Solid Pharmaceutical Composition Comprising Amlodipine and Losartan with Improved Stability
Solid Pharmaceutical Composition Comprising Amlodipine and Losartan and Process for Producing Same
Solid Pharmaceutical Composition Comprising Amlodipine and Losartan
Novel Intermediate and Process for Preparing Entecavir Using Same
Method for Preparing a Site-Specific Physiologically Active Polypeptide Conjugate
Novel Method for Preparing Entecavir and Intermediate Used Therein
Method of Preparing Sitagliptin and Intermediates Used Therein
Related Assignments
(23)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 15, 2004
From: GOLDSCHMIDT, JASON L.; SCHUBA, CHRISTOPH L.; SPEER, MICHAEL F.
To: SUN MICROSYSTEMS, INC.
Reel/Frame 015476/0047 →
Assignment of Assignor's Interest
Oct 25, 2004
From: YUN, SANGMIN; KIM, EUN SOOK; KIM, HEE SEOCK; KWON, BO SUNG
To: HANMI PHARM. CO., LTD.
Reel/Frame 015929/0266 →
Assignment of Assignor's Interest
Mar 14, 2006
From: HA, TAE HEE; OH, HEE SOOK; KIM, WON JEOUNG; PARK, CHANG HEE
To: HANMI PHARM. CO., LTD.
Reel/Frame 017688/0128 →
Assignment of Assignor's Interest
Mar 30, 2006
From: BANG, KEUK CHAN; CHAN, MI YOUNG; AHN, YOUNG GIL; HAM, YOUNG JIN
To: HANMI PHARM CO., LTD
Reel/Frame 017773/0267 →
Assignment of Assignor's Interest
Apr 14, 2006
From: JUNG, SUNG YOUB; KIM, JIN SUN; KWON, SE CHANG; LEE, GWAN SUN
To: HANMI PHARM. CO., LTD.
Reel/Frame 017814/0469 →
Assignment of Assignor's Interest
Oct 6, 2006
From: WOO, JONG SOO; YI, HONG-GI; CHI, MOON-HYUK; RYU, JAE-KUK
To: HANMI PHARM. CO., LTD.
Reel/Frame 018359/0031 →
Assignment of Assignor's Interest
Jan 26, 2007
From: LEE, JAEHEON; PARK, GHA-SEUNG; LEE, MOONSUB; KIM, CHEOL-KYONG
To: HANMI PHARM. CO., LTD.
Reel/Frame 018810/0063 →
Assignment of Assignor's Interest
Jan 30, 2007
From: LEE, JAEHEON; PARK, GHA SEUNG; LEE, MOONSUB; KIM, HAN KYONG
To: HANMI PHARM. CO., LTD.
Reel/Frame 018824/0149 →
Assignment of Assignor's Interest
Feb 22, 2007
From: LEE, JAEHEON; PARK, GHA SEUNG; LEE, MOONSUB; BANG, HYO-JEONG
To: HANMI PHARM. CO., LTD.
Reel/Frame 018920/0913 →
Assignment of Assignor's Interest
Jun 19, 2007
From: HAM, YOUNG JIN; GONG, JI HYEON; CHA, MI YOUNG; KIM, JONG WOO
To: HANMI PHARM. CO., LTD
Reel/Frame 019446/0640 →
Assignment of Assignor's Interest
Jul 5, 2007
From: WOO, JONG SOO; YI, HONG GI; JIN, JU NAM
To: HANMI PHARM. CO., LTD.
Reel/Frame 019518/0143 →
Assignment of Assignor's Interest
Dec 17, 2007
From: KIM, EUN SOOK; KIM, HEE CHEOL; KWON, BO SUNG; YUN, SANGMIN
To: HANMI PHARM. CO., LTD.
Reel/Frame 020255/0820 →
Assignment of Assignor's Interest
Jan 24, 2008
From: HA, TAE HEE; KIM, WON JEONG; OH, HEE SOOK; PARK, CHANG HEE
To: HANMI PHARM., LTD., CO.
Reel/Frame 020408/0911 →
Assignment of Assignor's Interest
Jun 13, 2008
From: WOO, JONG SOO; KIM, SANG WOOK; YI, HONG GI; RYU, JAE KUK
To: HANMI PHARM. CO., LTD
Reel/Frame 021091/0654 →
Assignment of Assignor's Interest
Dec 1, 2008
From: WOO, JONG SOO; YI, HONG GI; CHI, MOON HYUK; KIM, KYEONG SOO
To: HANMI PHARM. CO., LTD.
Reel/Frame 021906/0265 →
Assignment of Assignor's Interest
Oct 30, 2009
From: KIM, EUN SOOK; KIM, HEE CHEOL; KWON, BO SUNG; YUN, SANGMIN
To: HANMI PHARM. CO., LTD.
Reel/Frame 023447/0624 →
Assignment of Assignor's Interest
Jan 5, 2010
From: WOO, JONG SOO; YI, HONG GI; CHI, MOON HYUK; KIM, KYEONG SOO
To: HANMI PHARM. CO., LTD.
Reel/Frame 023734/0034 →
Assignment of Assignor's Interest
Jan 5, 2010
From: HA, TAE HEE; KIM, WON JEONG; OH, HEE SOOK; PARK, CHANG HEE
To: HANMI PHARM. CO., LTD.
Reel/Frame 023733/0921 →
Change of Name
Jan 7, 2011
From: HANMI PHARM. CO., LTD.
To: HANMI HOLDINGS CO., LTD.
Reel/Frame 025599/0842 →
Change of Name
Jan 7, 2011
From: HANMI PHARM. CO., LTD.
To: HANMI HOLDINGS CO., LTD.
Reel/Frame 025599/0984 →
Change of Name
Feb 18, 2011
From: HANMI PHARM. CO., LTD.
To: HANMI HOLDINGS CO., LTD.
Reel/Frame 025835/0319 →
Change of Name
Feb 18, 2011
From: HANMI PHARM. CO., LTD.
To: HANMI HOLDINGS CO., LTD.
Reel/Frame 025839/0380 →
Merger and Change of Name
Dec 16, 2015
From: ORACLE USA, INC.; SUN MICROSYSTEMS, INC.; ORACLE AMERICA, INC.
To: ORACLE AMERICA, INC.
Reel/Frame 037306/0514 →